MANILA, Philippines — Belgium’s Janssen Pharmaceutical has already secured the approval of the Vaccine Experts Panel (VEP) to conduct clinical trials in the country for its vaccine being developed against the coronavirus disease 2019 (COVID-19), the Department of Health (DOH) announced on Friday.
“Sinovac, Janssen, and Clover have been approved or given positive recommendations already by our Vaccine Experts Panel,” Health Undersecretary Maria Rosario Vergeire said in a virtual media forum.
Previously, only China’s Sinovac and Clover were earlier announced to have secured approval from the VEP of the Department of Science and Technology…
Keep on reading: Janssen gets nod of experts’ panel, moves closer to COVID vaccine clinical trials